Grail closes $300mm Series C round

15:40 EDT 22 May 2018 | Elsevier Business Intelligence

Cancer diagnostics company Grail Inc. raised $300mm through its Series C round. Ally Bridge Group, Hillhouse Capital Group, a...

Original Article: Grail closes $300mm Series C round

More From BioPortfolio on "Grail closes $300mm Series C round"